Fig. 3.
![Fig. 3. Whole blood coagulation and ASA. / Comparison of whole blood coagulation before (▪) and after (●) administration of ASA, 2 × 325 mg/d for 3 consecutive days. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times before ASA administration, arrow “b” after.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/97/8/10.1182_blood.v97.8.2314/5/h80810935003.jpeg?Expires=1723711953&Signature=Bu3uv14XW1yzrV9BQ0iIPVCPYwyCgFdnUG6KAG5OByNZ4N0mKtQVrz4khsJKyeBip6uDsfTNXQ1sX6KIIoMVrRAWdqgpbYvmeyRTg8h9OWi-qOVZoVuma0bV7xyzmEDNXRKmjpB7JYnMM5KnoYw~SVOXcxOiVqDiQ4HXgGouQvcsrJzZ1w9g6ji3kX4G4o-45jhoz~YDv3qCTCSkuSv7V2OF-DSFgx2PhjwDLdztBgVzYKTQ3w0gLyGpoPpQUVrMXacCZc4TcoSlFfmY399srMysE-GQdVDix7UaGEuwn69BP9Xc0TY0M1szXVf5a6j9TstvCs1yG4xa55or2HOT~w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Whole blood coagulation and ASA.
Comparison of whole blood coagulation before (▪) and after (●) administration of ASA, 2 × 325 mg/d for 3 consecutive days. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times before ASA administration, arrow “b” after.
